Advanced Therapy Pathway Cuts IBD Hospital Admissions

A Dutch multicentre study found that an advanced therapy care pathway for inflammatory bowel disease maintained disease control while significantly reducing hospital admissions. Among 1,173 patients, admissions fell six months after implementation, though emergency room visit reductions were not sustained. The pathway may standardise care without compromising outcomes.